BARBIERI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.387
EU - Europa 2.302
AS - Asia 1.952
SA - Sud America 311
AF - Africa 51
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.341
SG - Singapore 602
CN - Cina 513
IT - Italia 508
GB - Regno Unito 500
IE - Irlanda 346
HK - Hong Kong 256
BR - Brasile 232
SE - Svezia 217
VN - Vietnam 215
DE - Germania 211
FI - Finlandia 110
UA - Ucraina 105
RU - Federazione Russa 92
FR - Francia 66
IN - India 63
TR - Turchia 51
KR - Corea 44
BG - Bulgaria 37
ID - Indonesia 33
BD - Bangladesh 28
AR - Argentina 23
CA - Canada 20
IQ - Iraq 20
NL - Olanda 20
IR - Iran 18
ZA - Sudafrica 18
PL - Polonia 15
MX - Messico 14
ES - Italia 13
AE - Emirati Arabi Uniti 12
JP - Giappone 12
VE - Venezuela 12
EC - Ecuador 11
CL - Cile 10
CO - Colombia 10
MY - Malesia 10
PK - Pakistan 10
AZ - Azerbaigian 9
AU - Australia 8
TW - Taiwan 7
UZ - Uzbekistan 7
AT - Austria 6
BE - Belgio 6
EG - Egitto 6
NG - Nigeria 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
JO - Giordania 5
LT - Lituania 5
MT - Malta 5
PH - Filippine 5
AL - Albania 4
DO - Repubblica Dominicana 4
KE - Kenya 4
MA - Marocco 4
NP - Nepal 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
TH - Thailandia 4
UY - Uruguay 4
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
LV - Lettonia 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
GA - Gabon 1
HU - Ungheria 1
KZ - Kazakistan 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
Totale 9.013
Salva come PNG Salva come JPEG
Città #
Santa Clara 431
Singapore 416
Ashburn 360
Dublin 346
Fairfield 322
Southend 298
Chandler 265
Hong Kong 252
Woodbridge 224
San Jose 204
Houston 184
Jacksonville 176
Dearborn 168
Ann Arbor 162
Beijing 151
Nyköping 131
Chicago 123
Wilmington 120
Seattle 118
Cambridge 107
Los Angeles 98
London 88
Hefei 82
Helsinki 79
The Dalles 69
Ho Chi Minh City 64
New York 64
Modena 57
Council Bluffs 55
Hanoi 46
Dallas 44
Munich 43
Seoul 43
Moscow 37
Princeton 37
Salt Lake City 37
Sofia 35
Eugene 32
Izmir 30
Lauterbourg 30
Shanghai 29
Jakarta 27
Rome 27
São Paulo 27
Tampa 26
Elk Grove Village 25
San Diego 25
Bremen 24
Dong Ket 22
Orem 22
Bologna 20
Milan 18
Columbus 17
Buffalo 16
Fremont 16
Sterling 15
Lancaster 14
Redwood City 14
Frankfurt am Main 11
Haiphong 11
Phoenix 11
Amsterdam 10
Atlanta 10
Catania 10
Florence 10
Palermo 10
Turku 10
Da Nang 9
Norwalk 9
Poplar 9
Redondo Beach 9
Tokyo 9
Brasília 8
Chennai 7
Denver 7
Des Moines 7
Falls Church 7
Naples 7
Rio de Janeiro 7
San Mateo 7
Tashkent 7
Warsaw 7
Baku 6
Belo Horizonte 6
Brooklyn 6
Cape Town 6
Dhaka 6
Dulles 6
Ferrara 6
Johannesburg 6
Mumbai 6
Nanjing 6
Padova 6
Pittsburgh 6
Santiago 6
Stockholm 6
Amman 5
Bogotá 5
Brescia 5
Chengdu 5
Totale 6.325
Salva come PNG Salva come JPEG
Nome #
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 477
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 424
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 415
Use of Recombinant Factor IX and Thromboelastography in a Patient With Hemophilia B Undergoing Liver Transplantation: A Case Report 390
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 377
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma 338
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer 327
Achievements and unmet needs in the management of advanced ovarian cancer 321
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 321
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 319
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 304
Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications 294
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 293
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy 286
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 278
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 259
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 250
Biomarkers predicting clinical benefit: fact or fiction? 243
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 242
Timing for starting second-line therapy in recurrent ovarian cancer 239
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 234
P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 226
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens. 223
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 220
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 215
Tumori ginecologici 213
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 211
ACHIEVEMENTS AND UNMET NEEDS IN THE MANAGEMENT OF EPITHELIAL OVARIAN CANCER 193
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 187
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 181
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 180
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 153
Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues. 152
PREDICTIVE AND PROGNOSTIC ROLE OF P53 EXPRESSION IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY: A SINGLE INSTITUTION ANALYSIS 97
Totale 9.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 0 0 0 0 54 57 36
2021/2022539 9 86 57 12 11 23 27 13 64 45 121 71
2022/20231.047 97 98 58 76 71 103 13 62 403 11 29 26
2023/2024559 24 21 40 39 71 46 49 118 21 27 44 59
2024/20251.508 17 41 35 110 308 251 86 104 161 69 132 194
2025/20262.863 186 68 206 407 689 198 414 140 271 284 0 0
Totale 9.082